Published in J Clin Microbiol on September 15, 2010
Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev (2012) 1.23
Assessing mathematical models of influenza infections using features of the immune response. PLoS One (2013) 1.05
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol (2013) 1.04
Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding. Biophys J (2012) 1.02
Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting. PLoS One (2011) 1.02
Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis. Antimicrob Agents Chemother (2011) 0.86
Estimation of the relative sensitivity of qPCR analysis using pooled samples. PLoS One (2014) 0.78
Ability of device to collect bacteria from cough aerosols generated by adults with cystic fibrosis. F1000Res (2016) 0.75
Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep (2009) 3.43
Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol (2010) 2.55
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med (2009) 1.86
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med (2009) 1.79
H1N1 pneumonitis treated with intravenous zanamivir. Lancet (2009) 1.73
Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Res (2009) 1.66
Overview of real-time RT-PCR strategies for quantification of gene rearrangements in the myeloid malignancies. Methods Mol Med (2006) 0.92
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol (2009) 9.43
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med (2007) 7.91
Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 5.96
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis (2006) 4.88
Prevalence of off-target effects in Drosophila RNA interference screens. Nature (2006) 3.38
The ihog cell-surface proteins bind Hedgehog and mediate pathway activation. Cell (2006) 2.92
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy (2007) 2.10
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci U S A (2008) 2.10
A genomewide screen for components of the RNAi pathway in Drosophila cultured cells. Proc Natl Acad Sci U S A (2006) 2.04
Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J Mol Cell Cardiol (2011) 1.93
Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development. Development (2011) 1.92
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother (2010) 1.87
Extensive phosphorylation of Smoothened in Hedgehog pathway activation. Proc Natl Acad Sci U S A (2004) 1.81
A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis (2002) 1.77
Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center. Infect Control Hosp Epidemiol (2011) 1.70
Stromal-epithelial crosstalk regulates kidney progenitor cell differentiation. Nat Cell Biol (2013) 1.64
Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol (2003) 1.57
Genome-wide RNAi screen reveals disease-associated genes that are common to Hedgehog and Wnt signaling. Sci Signal (2011) 1.45
In vivo Wnt signaling tracing through a transgenic biosensor fish reveals novel activity domains. Dev Biol (2012) 1.43
Daptomycin failure in a neutropenic leukemia patient with Staphylococcus aureus meningitis. Leuk Lymphoma (2012) 1.40
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020. Emerg Infect Dis (2020) 1.40
Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine. J Biol Chem (2012) 1.33
Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem (2003) 1.32
Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.26
Structure-activity relationship studies of small-molecule inhibitors of Wnt response. Bioorg Med Chem Lett (2009) 1.24
Deconstructing the hedgehog pathway in development and disease. Science (2007) 1.18
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression. Proc Natl Acad Sci U S A (2011) 1.16
Epstein Barr virus-associated acute acalculous cholecystitis: a rare occurrence but favorable outcome. Clin Pediatr (Phila) (2010) 1.14
Lumboperitonial shunt infection due to Chryseobacterium indologenes. Pediatr Infect Dis J (2007) 1.12
Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol (2012) 1.10
Tankyrase is necessary for canonical Wnt signaling during kidney development. Dev Dyn (2010) 1.09
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections. Am J Infect Control (2012) 1.08
Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation. Clin Transplant (2010) 1.08
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother (2012) 1.07
Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther (2010) 1.04
Fluconazole-resistant Candida albicans vulvovaginitis. Obstet Gynecol (2012) 1.04
Multicenter evaluation of a new shortened peptide nucleic acid fluorescence in situ hybridization procedure for species identification of select Gram-negative bacilli from blood cultures. J Clin Microbiol (2010) 1.03
Treatment of resistant enterococcal urinary tract infections. Curr Infect Dis Rep (2010) 1.02
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother (2010) 1.01
Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests. Infect Control Hosp Epidemiol (2012) 1.01
Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus. J Antimicrob Chemother (2003) 1.00
Polymicrobial candidemia. Diagn Microbiol Infect Dis (2002) 1.00
Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods. J Clin Microbiol (2013) 0.99
An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol (2010) 0.99
A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clin Cancer Res (2013) 0.98
The development of highly potent inhibitors for porcupine. J Med Chem (2013) 0.97
Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents (2008) 0.97
Drugging the cancer stem cell compartment: lessons learned from the hedgehog and Wnt signal transduction pathways. Annu Rev Pharmacol Toxicol (2011) 0.97
Novel effect of voriconazole on conidiation of Aspergillus species. Int J Antimicrob Agents (2004) 0.96
Asaia lannaensis bloodstream infection in a child with cancer and bone marrow transplantation. J Med Microbiol (2009) 0.95
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2011) 0.95
Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates. Transplantation (2008) 0.93
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients. Infect Drug Resist (2012) 0.93
Group B Streptococcus infections in non-pregnant adults: the role of immunosuppression. Int J Infect Dis (2012) 0.92
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.91
"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control (2012) 0.89
Severe cytomegalovirus enterocolitis in an immunocompetent infant. Pediatr Infect Dis J (2004) 0.89
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin. Infect Control Hosp Epidemiol (2012) 0.88
Pasteurella multocida urinary tract infection in a pediatric patient with end-stage renal disease. Pediatr Infect Dis J (2007) 0.88
Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients. Clin Transplant (2007) 0.88
Hedgehog signaling pathway. Sci STKE (2007) 0.88
The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control (2012) 0.88
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Ann Pharmacother (2012) 0.87
Significance of high-risk human papillomavirus DNA-positive atypical squamous cells of undetermined significance pap smears in perimenopausal and postmenopausal women. Acta Cytol (2008) 0.86
Increased prevalence of methicillin-resistant Staphylococcus aureus nasal colonization in household contacts of children with community acquired disease. BMC Infect Dis (2012) 0.86
Chemical and biological studies of nakiterpiosin and nakiterpiosinone. J Am Chem Soc (2010) 0.85
Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus. Clin Transplant (2005) 0.85
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother (2012) 0.85
Intravenous and inhalational colistin-induced respiratory failure. Clin Infect Dis (2010) 0.85
Immediate cross-hypersensitivity between micafungin and caspofungin: a case report. J Oncol Pharm Pract (2009) 0.84
Appropriate use of polymerase chain reaction for detection of herpes simplex virus 2 in cerebrospinal fluid of patients at an inner-city hospital. Diagn Microbiol Infect Dis (2006) 0.83
Emergence of human rotavirus genotype G9 in metropolitan Detroit between 2007 and 2009. J Med Microbiol (2011) 0.83
West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant (2004) 0.83
A multiplexed luciferase-based screening platform for interrogating cancer-associated signal transduction in cultured cells. J Vis Exp (2013) 0.83
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial. Biol Blood Marrow Transplant (2012) 0.83
Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol (2014) 0.83
A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro. Diagn Microbiol Infect Dis (2009) 0.82
Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma. J Chemother (2012) 0.82
Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10. J Antibiot (Tokyo) (2013) 0.81
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma. Support Care Cancer (2013) 0.81
Hedgehog signaling pathway in Drosophila. Sci STKE (2007) 0.81
Emerging trends in infections among renal transplant recipients. Expert Rev Anti Infect Ther (2004) 0.81
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function. Biol Blood Marrow Transplant (2012) 0.80
Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis. J Antimicrob Chemother (2002) 0.80
Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit. Diagn Microbiol Infect Dis (2011) 0.78
Hospital bath basins are frequently contaminated with multidrug-resistant human pathogens. Am J Infect Control (2011) 0.78
The Chemistry and Biology of Nakiterpiosin - C-nor-D-Homosteroids. Synlett (2012) 0.78
Clostridial liver abscess following blunt abdominal trauma: case report and review of the literature. Scand J Infect Dis (2007) 0.78